Mar. Drugs 2014, 12(2), 799-821; doi:10.3390/md12020799

Isolation and Characterization of Anti-Adenoviral Secondary Metabolites from Marine Actinobacteria

1,†email, 2,†email, 2email, 1email, 1email, 2email, 3email, 1email, 2email, 3email, 1email and 2,* email
Received: 17 December 2013; in revised form: 10 January 2014 / Accepted: 15 January 2014 / Published: 28 January 2014
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Adenovirus infections in immunocompromised patients are associated with high mortality rates. Currently, there are no effective anti-adenoviral therapies available. It is well known that actinobacteria can produce secondary metabolites that are attractive in drug discovery due to their structural diversity and their evolved interaction with biomolecules. Here, we have established an extract library derived from actinobacteria isolated from Vestfjorden, Norway, and performed a screening campaign to discover anti-adenoviral compounds. One extract with anti-adenoviral activity was found to contain a diastereomeric 1:1 mixture of the butenolide secondary alcohols 1a and 1b. By further cultivation and analysis, we could isolate 1a and 1b in different diastereomeric ratio. In addition, three more anti-adenoviral butenolides 2, 3 and 4 with differences in their side-chains were isolated. In this study, the anti-adenoviral activity of these compounds was characterized and substantial differences in the cytotoxic potential between the butenolide analogs were observed. The most potent butenolide analog 3 displayed an EC50 value of 91 μM and no prominent cytotoxicity at 2 mM. Furthermore, we propose a biosynthetic pathway for these compounds based on their relative time of appearance and structure.
Keywords: adenovirus; antiviral; natural products; secondary metabolites; marine actinobacteria; extract screening; butenolides
PDF Full-text Download PDF Full-Text [1429 KB, uploaded 28 January 2014 13:59 CET]

Export to BibTeX |

MDPI and ACS Style

Strand, M.; Carlsson, M.; Uvell, H.; Islam, K.; Edlund, K.; Cullman, I.; Altermark, B.; Mei, Y.-F.; Elofsson, M.; Willassen, N.-P.; Wadell, G.; Almqvist, F. Isolation and Characterization of Anti-Adenoviral Secondary Metabolites from Marine Actinobacteria. Mar. Drugs 2014, 12, 799-821.

AMA Style

Strand M, Carlsson M, Uvell H, Islam K, Edlund K, Cullman I, Altermark B, Mei Y-F, Elofsson M, Willassen N-P, Wadell G, Almqvist F. Isolation and Characterization of Anti-Adenoviral Secondary Metabolites from Marine Actinobacteria. Marine Drugs. 2014; 12(2):799-821.

Chicago/Turabian Style

Strand, Mårten; Carlsson, Marcus; Uvell, Hanna; Islam, Koushikul; Edlund, Karin; Cullman, Inger; Altermark, Björn; Mei, Ya-Fang; Elofsson, Mikael; Willassen, Nils-Peder; Wadell, Göran; Almqvist, Fredrik. 2014. "Isolation and Characterization of Anti-Adenoviral Secondary Metabolites from Marine Actinobacteria." Mar. Drugs 12, no. 2: 799-821.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert